Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV resistance testing in the USA--a model for the application of pharmacogenomics in the clinical setting.

Pharmacogenomics - 1 Mar 2005

Blum Ronald A, Wylie Neil, England Tom, French Cynthia

Abstract excerpt

Although there is debate about how and when the medical community will readily adopt pharmacogenomics into clinical practice, HIV genotyping has become an integral part of AIDS patient management in the USA since 1996. Genotyping for HIV-1 drug resistance serves as a paradigm for the way pharmacogenomics is likely to be introduced into patient care. This review discusses the unique role that HIV-1 genotype...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Genomics

Share to HLA Antigens

Share to Pharmacogenetics

Share to United States

Source

Identifiers

PMID: 15882135
DOI: 10.1517/14622416.6.2.169

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV resistance testing in the USA--a model for the application of pharmacogenomics in the clinical setting.PMID 15882135Read ↗

Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 1).Semantic proximity Read ↗

Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2).Semantic proximity Read ↗

Antiretroviral resistance testing for clinical management.Semantic proximity Read ↗

Update on antiretroviral drug resistance testing: combining laboratory technology with patient care.Semantic proximity Read ↗

Antiretroviral drug resistance testing.Semantic proximity Read ↗

HIV-1 drug resistance genotyping. A review of clinical and economic issues.Semantic proximity Read ↗

Genotypic resistance testing in routine clinical care.Semantic proximity Read ↗

The evolving role of antiretroviral drug resistance testing in HIV-infected individuals.Semantic proximity Read ↗

Human immunodeficiency virus drug resistance testing: state of the art in genotypic and phenotypic testing of antiretrovirals.Semantic proximity Read ↗

HIV resistance testing: an update.Semantic proximity Read ↗

The benefits of HIV resistance testing in optimizing drug discovery.Semantic proximity Read ↗

Is resistance testing of benefit in treatment-naive HIV-infected patients?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.